<SEC-DOCUMENT>0001558370-21-016882.txt : 20211216
<SEC-HEADER>0001558370-21-016882.hdr.sgml : 20211216
<ACCEPTANCE-DATETIME>20211216161612
ACCESSION NUMBER:		0001558370-21-016882
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20211215
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211216
DATE AS OF CHANGE:		20211216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Inotiv, Inc.
		CENTRAL INDEX KEY:			0000720154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				351345024
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23357
		FILM NUMBER:		211497961

	BUSINESS ADDRESS:	
		STREET 1:		2701 KENT AVE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382
		BUSINESS PHONE:		3174634527

	MAIL ADDRESS:	
		STREET 1:		2701 KENT AVENUE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOANALYTICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19970918
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>notv-20211215x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.6.8003.26990 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 12/16/2021 9:03:31 PM -->
      <!-- iXBRL Library version: 1.0.8003.27000 -->
      <!-- iXBRL Service Job ID: d20c9937-1a3b-44a7-bd10-b4070489dac9 -->

  <html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:notv="http://www.inotivco.com/20211215" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:EntityCentralIndexKey" id="Tc_g6PSrfgzkUCGMC3FqSw6ug_2_1">0000720154</ix:nonNumeric><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:AmendmentFlag" id="Tc_bF_mp4QupEOR7nGMPYlqaQ_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="notv-20211215.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000720154</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-15</xbrli:startDate><xbrli:endDate>2021-12-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_a41134a3_845c_4346_ab5e_17345b9d291b"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM </b><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:DocumentType" id="Narr_77YHLgdt9EOJdoRGxfdltA"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_kjrm5dZRx0uwB_oDNVWijg">December 15, 2021</ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_a797269c_e1cd_4e90_be4b_aecbd3b08b7e"></a><a id="Tc_cfzXcZcoIkG6owlIsMsUGw_2_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:EntityRegistrantName" id="Tc_GBSMdiHo9EKrNvABLWTzbA_1_0"><b style="font-weight:bold;">INOTIV, INC.</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Exact name of registrant as specified in<br />its charter)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_3d79b89a_f3a8_4036_81de_60c1c144f0c3"></a><a id="Tc_9BqFxbs6VEKUV7HGomTj8A_2_0"></a><a id="Tc_ByacRVwfxE2Z5Hq_Ao6rHw_2_2"></a><a id="Tc_FgV7uGsvUkmKdcAqpf-BgQ_2_4"></a><a id="Tc_4bFXvCBX_UezL-yYL0oQcQ_3_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:31.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:31.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:31.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:31.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_kn-HP-DlOE-BhkMOMgr5hA_1_0"><b style="font-weight:bold;">Indiana</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:31.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:EntityFileNumber" id="Tc_FbaY2sEQ_UOs3N9b9MJ28Q_1_2"><b style="font-weight:bold;">0-23357</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:31.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:EntityTaxIdentificationNumber" id="Tc_1L0saysr7U2Mw1LKje1K5w_1_4"><b style="font-weight:bold;">35-1345024</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:31.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(State or other<br />jurisdiction of</p></td><td style="vertical-align:top;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Commission File<br />Number)</p></td><td style="vertical-align:top;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(I.R.S. Employer<br />Identification No.)</p></td></tr><tr><td style="vertical-align:top;width:31.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">incorporation or<br />organization)</p></td><td style="vertical-align:top;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_a19cab2e_e55e_49c1_924f_4499e92d25a8"></a><a id="Tc_Pn4BUoCSh0ixx3tODUZqag_2_0"></a><a id="Tc_aQ94qq6nuUaA2rvgz9bG3g_3_0"></a><a id="Tc_XKAIMKTKZUyL_wwlcNcWfQ_3_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:99.89%;"><tr style="height:1pt;"><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:EntityAddressAddressLine1" id="Tc_0F0MZW2n8UuqnEdj-COOlQ_1_0"><b style="font-weight:bold;">2701 Kent Avenue</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:EntityAddressCityOrTown" id="Narr_dxNck9YGX0yOEU3jCr6_0g"><b style="font-weight:bold;">West Lafayette</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="Narr_56AWTPCfZU6x2HD-m4xhOw"><b style="font-weight:bold;">Indiana</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:EntityAddressPostalZipCode" id="Tc_VfQEKD-CuEOaXVzelz1DJg_2_2"><b style="font-weight:bold;">47906-1382</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Address of principal executive offices)</p></td><td style="vertical-align:top;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Zip Code)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Registrant&#8217;s telephone number, including area code: <b style="font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:CityAreaCode" id="Narr_uboUPmLclUKdTzw1ME0bkw"><b style="font-weight:bold;">765</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:LocalPhoneNumber" id="Narr_KIatB_QdzkqtB39YVU3ngQ"><b style="font-weight:bold;">463-4527</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18.3pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_cBx0Vi5kfUaBBQxkcy5T1g"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18.3pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_vUdGAJZB5EOrITjTrJBu3Q"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Soliciting material pursuant to Rule 14a-12 under the Exchange Act(17CFR240.14a-12)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18.3pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_bazxvagHMkqhQdU4Xi0NnQ"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act(17CFR240.14d-2(b))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18.3pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_hXlUe9-FSUyol3vQ75V3JQ"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act(17CFR240.13e-4(c))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_e8a20ad2_88ee_4dd7_a4b3_72dd37824f69"></a><a id="Tc_7E1LTuRCB0WV9Q2GwoOLww_0_0"></a><a id="Tc_7wVnX00mTk6lt8SjZ_VOQg_0_2"></a><a id="Tc_Hzwtp65EAESdilX7osoZ0Q_0_4"></a><a id="Tc_jDKMJTAAH0ekFm98a6qNyA_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:31.95%;border-left:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Title of each class</p></td><td style="vertical-align:top;width:2.06%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:23.48%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Trading Symbols</p></td><td style="vertical-align:top;width:2.57%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:39.92%;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Name of exchange on which registered</p></td></tr><tr><td style="vertical-align:top;width:31.95%;border-bottom:1px solid #000000;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:Security12bTitle" id="Tc_K25YpyGdHkKeYh4P7TQvaQ_1_0">Common Shares</ix:nonNumeric></p></td><td style="vertical-align:top;width:2.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:23.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:TradingSymbol" id="Tc_lIajkjObiUiPopfb4pUrJg_1_2">NOTV</ix:nonNumeric></p></td><td style="vertical-align:top;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:39.92%;border-bottom:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" name="dei:SecurityExchangeName" id="Narr_0dww8cleOUeo_nPe3BfKMw">NASDAQ</ix:nonNumeric> Capital Market</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_xy7fkM06fkSyvTkggzYJ6g"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Segoe UI Symbol';font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:justify;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;text-align:justify;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_b31210f2_3d75_4c38_8a0b_89a17dd3b36a"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="background:#ffffff;">The information provided in Item 2.02 and Item 9.01 of this Form 8-K is being furnished and shall not be deemed &quot;filed&quot; for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 and Item 9.01 of this Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Item 2.02 Results of Operations and Financial Condition.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">On December 16, 2021, Inotiv, Inc. issued a press release announcing financial results for the three and twelve months of fiscal 2021 ended September 30, 2021. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_1bc9ca9b_27a6_4ad9_adbf_06684e8fed86"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Item 4.02 Non-reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">On December 15, 2021, the Company&#39;s management and the Audit Committee of the Board of Directors concluded that, due to a failure to properly account for certain tax attributes related to an acquisition that occurred in the Company&#39;s third fiscal quarter, the Company&#39;s previously issued unaudited interim financial statements as of and for the three and nine months ended June 30, 2021 included in the Company&#39;s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (&quot;SEC&quot;) on August 13, 2021 should no longer be relied upon. &#160;Specifically, management and the Audit Committee concluded that, in accordance with ASC 805-740, the Company should have established a deferred tax liability with an offset to goodwill in connection with the accounting for the opening balance sheet of the Bolder BioPATH acquisition as a result of book-to-tax differences primarily related to the customer relationship intangible and property and equipment identified in the Company&#8217;s June 30, 2021 quarterly financial statements. Subsequent to the establishment of the deferred tax liability as of the opening balance sheet, the Company should have reversed a portion of its (i.e. the acquiror) pre-existing valuation allowance and taken the income tax benefit through the statement of operations for the three and nine months ended June 30, 2021. &#160;The impact of these adjustments is to increase the amount of goodwill and deferred tax liability recorded on the June 30, 2021 balance sheet by approximately $4.9 million and to reduce our valuation allowance recorded on the June 30, 2021 balance sheet and increase income tax benefit in the statements of operations for the three and nine month periods ended June 30, 2021 by approximately $4.9 million. &#160;Each of these adjustments is a non-cash item.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Company intends to restate its historical financial results as soon as possible for the affected periods in an amendment to its Quarterly Report on Form 10-Q for the period ended June 30, 2021 as filed with the Commission on August 13, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Company&#8217;s management has concluded that in light of the error described above, a material weakness existed in the Company&#8217;s internal control over financial reporting related to accounting for taxes relating to acquisitions that qualify as a stock acquisition for tax purposes and that the Company&#8217;s disclosure controls and procedures were not effective &#160;as of June 30, 2021. The Company&#8217;s remediation plan with respect to such material weakness includes engaging with highly qualified tax advisors and will be described in more detail in the amendment to the third quarter Form 10-Q.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Company&#39;s Audit Committee discussed the matters described in this Item 4.02 with RSM US LLP, the Company&#39;s independent registered accounting firm.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_3875ac32_0bc8_40ae_93c6_50161a9406a6"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Item 9.01 Financial Statements and Exhibits</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Not applicable.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 54pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Not applicable.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(c)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Not applicable.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 54pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(d)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Exhibits</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><div style="padding-left:40.5pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:91.55%;"><tr style="height:1pt;"><td style="vertical-align:top;width:7.08%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:92.91%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:7.08%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">99.1</p></td><td style="vertical-align:top;width:92.91%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="notv-20211215xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Inotiv, Inc. press release dated December 16, 2021.</span></a></p></td></tr><tr><td style="vertical-align:top;width:7.08%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">104</p></td><td style="vertical-align:top;width:92.91%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_98c3696c_ec68_48b2_8700_37993980c4e5"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:2.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:30%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:16.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="3" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Inotiv, Inc.</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:30%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:30%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: December 16, 2021</p></td><td style="vertical-align:top;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:47%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Beth A. Taylor</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="3" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Beth A. Taylor</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="3" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer, Vice President &#8211; Finance</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>notv-20211215xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 12/16/2021 09:03:50 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:28.8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;">Exhibit 99.1</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.17;text-align:center;margin:0pt;"><b style="font-size:15pt;font-weight:bold;">Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">WEST LAFAYETTE, IN, December 16, 2021</b> <font style="font-size:12pt;">&#8211; </font><b style="font-size:12pt;font-weight:bold;">Inotiv, Inc. (NASDAQ: NOTV) (the &#8220;Company&#8221;, &#8220;We&#8221;, &#8220;Our&#8221; or &#8220;Inotiv&#8221;)</b><font style="font-size:12pt;">, </font>a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (&#8220;Q4 FY 2021&#8221;) and twelve months (&#8220;12M FY 2021&#8221;) ended September 30, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 4pt 0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">4Q FY 2021 Highlights</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Revenue grew 90.7% to $30.1 million, from $15.8 million during the three months ended September 30, 2020 (&#8220;Q4 FY 2020&#8221;), driven by internal growth of $6.7 million and incremental revenue from HistoTox Labs, Inc. (&#8220;HistoTox Labs&#8221;), Bolder BioPATH, Inc. (&#8220;Bolder BioPATH&#8221;) and Gateway Pharmacology Laboratories LLC (&#8220;Gateway Pharmacology&#8221;) totaling $7.6 million. &#160;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Gross profit increased 123.0% to $10.3 million, from $4.6 million in Q4 FY 2020, reflecting higher revenue and a 496 basis point expansion in gross margin to 34.3%. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Operating loss totaled $(3.4) million, compared to an operating loss of $(1.4) million in Q4 FY 2020, reflecting an increase in operating expenses, which more than offset higher gross profit on higher revenue. </font><font style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">The increase in operating expenses reflects higher strategic investment in unallocated corporate general and administrative expense (&#8220;G&amp;A&#8221;) to support additional future revenue growth, which included recruiting and relocation expense, higher compensation expense (including non-cash stock compensation), &#160;transaction costs related to the acquisition</font><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;"> of Envigo RMS Holding Corp. (or &#8220;Envigo&#8221;) incurred through September 30, 2021 prior to the closing, an increase in sales commissions due to higher sales awards and an increase in startup costs for internal investments in new service offerings. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Net income was $9.4 million, or $0.06 per diluted share, compared to a net loss of $(1.8) million, or $(0.16) per diluted share, in Q4 FY 2020. Net income for Q4 FY 2021 includes the positive impact of the forgiveness of the Company&#39;s Paycheck Protection Program loan (&#8220;PPP&#8221;) in the amount of $4.9 million and $8.4 million of fair value remeasurement on the convertible notes issued in September 2021.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Adjusted EBITDA increased to $4.3 million, from $156,000 in Q4 FY 2020.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Book-to-bill ratio of 1.77x for services business. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Ending backlog of $81.4 million, up 31.3% compared to $62.0 million at June 30, 2021, and up 85.8% from $43.8 million at September 30, 2020.</font></td></tr></table><div style="margin-top:4pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 0pt 4pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 4pt 0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">12M FY 2021 Highlights</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Revenue grew 48.2% to $89.6 million, from $60.5 million during the twelve months ended September 30, 2020 (&#8220;12M FY 2020&#8221;), driven by internal growth of $17.3 million and incremental revenue from HistoTox Labs, Bolder BioPATH and Gateway Pharmacology totaling $11.8 million. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Gross profit increased 65.4% to $30.2 million, from $18.2 million in 12M FY 2020, reflecting higher revenue and a 350 basis point expansion in gross margin to 33.7%. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Operating loss totaled $(5.6) million, compared to an operating loss of $(3.1) million in 12M FY 2020, reflecting an increase in operating expenses, including those impacting the 4Q FY 2021 results, which more than offset higher gross profit on higher revenue. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Net income was $10.9 million, or $0.19 per diluted share, compared to a net loss of $(4.7) million, or $(0.43) per diluted share, in 12M FY 2020. Net income for 12M FY 2021 includes the positive impact </font></td></tr></table></div><div style="clear:both;margin-bottom:28.8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">of the loan forgiveness and fair value remeasurement noted above, and the impact of a non-cash tax benefit of $5.0 million relating to a partial release of the Company&#8217;s valuation allowance for deferred tax liabilities acquired with the acquisitions of Bolder BioPATH and Gateway. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Adjusted EBITDA increased 223.5% to $9.3 million, from $2.9 million in 12M FY 2020.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.7pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Book-to-bill ratio of 1.52x for services business. </font></td></tr></table><div style="margin-top:4pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 0pt 4pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 4pt 0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Significant Events during Q4 FY 2021</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">On July 12, 2021, announced the acquisition of assets from MilliporeSigma&#8217;s BioReliance&#174; portfolio to expand genetic toxicology offering and hiring of Gopala Krishna, PhD, to build and lead the startup of the genetic toxicology business.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">On July 15, 2021, announced the acquisition of laboratory instrumentation to accelerate the startup and development of laboratory services pursuing cell and gene therapy as well as traditional biotherapeutics and immunotherapies.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">On August 2, 2021, announced the acquisition of Gateway Pharmacology </font><font style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">for increased drug metabolism &amp; pharmacokinetics (DMPK) technology and capability, as well as a new cell and molecular biology suite capable of delivering in vitro solutions in pharmacology and toxicology early in drug discovery</font><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">On September 21, 2021, announced the entry into an agreement to purchase Envigo, a leading global provider of research models and services.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">On September 27, 2021, announced the closing of an offering of $140,000,000 aggregate principal amount of 3.25% convertible senior notes due 2027, including $15,000,000 of additional notes, in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">During the quarter, received notice that the PPP loan was forgiven for $4.9 million.</font></td></tr></table><div style="margin-top:4pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 0pt 4pt 0pt;"><font style="font-size:11pt;font-weight:bold;text-decoration:underline;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 4pt 0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">Subsequent Events</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">On October 4, 2021, announced the acquisition of </font><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-align:justify;"><a name="_Hlk89246118"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">Plato BioPharma</font><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">, Inc., a Colorado-based </font><i style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:italic;font-weight:normal;text-align:justify;">in vivo</i><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;"> pharmacology research and drug discovery company specializing in cardiovascular, renal, pulmonary and hepatic therapeutic areas. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">On November 2, 2021, the Audit Committee of the Board of Directors of the Company approved the </font><font style="background-color:#ffffff;font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">engagement of Ernst &amp; Young as its new independent registered public accountants for the fiscal year ending September 30, 2022 effective immediately following the completion by RSM of the 2021 Audit</font><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:4pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">On November 5, 2021, announced the completion of the acquisition of Envigo for base cash consideration of $271.0 million, including adjustments for net working capital and cash balances as provided in the merger agreement of approximately $13.0 million and $48.0 million, respectively, and 9,036,538 Inotiv common shares. The common shares included in the merger consideration include 790,620 shares issuable upon the exercise of certain Envigo stock options that were assumed by the Company in the transaction.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:13.5pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">In connection with the acquisition of Envigo, the Company announced on November 5, 2021 a new senior secured term loan facility of $165.0 million to fund the cash portion of the acquisition, in addition to using net proceeds from the convertible notes. The term loan facility will accrue interest at the prevailing LIBOR rate, plus a margin of between 6.00% and 6.50%. The initial interest rate is LIBOR plus 6.25%, and the term loan facility will mature on November 5, 2026.</font></td></tr></table><div style="margin-top:4pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:28.8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt;">Robert Leasure, Jr., the Company&#39;s President and Chief Executive Officer, commented, &#8220;Our strong fourth quarter fiscal 2021 financial results capped off a transformational year for Inotiv, reflecting our success expanding existing operations and services, starting up new services, and acquiring strategic assets. In fiscal 2021, we invested in state-of-the-art DMPK and cell and molecular biology laboratories at our St. Louis facility and additional vivarium capacity at our West Lafayette facility. We also developed new in-house capabilities through internal startups in the areas of SEND reporting, cardio safety pharmacology, clinical pathology, biotherapeutics, histopathology for devices, and genetic toxicology. And we consummated the strategic acquisitions of HistoTox Labs, Bolder BioPATH, and Gateway Pharmacology, as well as critical genetic toxicology assets and modern cell and molecular biology instrumentation. Finally, we made significant growth-enabling investments in G&amp;A, including in our people, infrastructure, and systems.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt;">Mr. Leasure concluded, &#8220;We continued our momentum after quarter-end, completing the acquisitions of Plato BioPharma, a complementary <i style="font-style:italic;">in vivo</i> pharmacology platform, and Envigo, a leading global provider of research models and services. Envigo adds meaningful scale, expands our geographic footprint, diversifies our customer base, and creates significant cross-selling opportunities. Reported earnings this quarter and fiscal year were impacted by our strategic investments in internal startup costs, acquisition-related expenses, and recruiting and retention-related expenses. We believe that the investments we are making today will drive future growth and deliver higher operating margins and improved service for our clients. Over the longer term, we are targeting organic revenue growth in the high-single to low-double digits and EBITDA margins in the range of 18% to 22%. In the near-term, we are optimistic for continued strong revenue growth based on our quarter-end backlog of $81.4 million as well as anticipated contributions from recent acquisitions, internal expansions and new services.&#8221; </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 4pt 0pt;"><b style="font-weight:bold;">Q4 FY 2021 Review </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;">Revenue increased 90.7% to $30.1 million, compared with $15.8 million in Q4 FY 2020, which was primarily driven by our service segment. Service segment revenue for Q4 FY 2021 increased 93.3% to $29.0 million, from $15.0 million in the prior year period. The increase in Service revenue was due to internal growth year over year as well as incremental revenue from the acquisitions of HistoTox Labs, Bolder BioPATH and Gateway Pharmacology<b style="font-weight:bold;">. </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt;">Cost of Service revenue as a percentage of Service revenue decreased to 65.8% in Q4 FY 2021, from 71.1% in the prior year period, reflecting greater utilization of recently expanded capacity. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt;">Product segment revenue increased 40.9% to $1.1 million in Q4 FY 2021, from $0.8 million in the prior year period.<b style="font-weight:bold;"> &#160;</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;">Cost of Product revenue as a percentage of Product revenue increased to 64.4% in Q4 FY 2021 from 63.4 % in the prior year period, due to mix of products sold. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;">Operating expenses increased by 128.8%, or $7.7 million, as the Company continued to build the infrastructure for growth, which included additional headcount, recruiting, relocation expense, sales commissions, non-cash stock compensation expense, costs associated with acquisitions and investments in building out new service offerings. Additionally, there was an increase in selling expenses due to an increase in travel cost as our sales and marketing teams have traveled more as the COVID-19 pandemic eases and an increase in commissions due to higher sales awards.<font style="font-size:12pt;"> </font>During Q4 FY 2021, we continued investing in additional service offerings that we brought in house such as laboratory solutions, medical device pathology, biotherapeutics and genetic toxicology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:28.8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_Hlk79491363"></a></font>The Company believes that unallocated corporate G&amp;A as a percentage of revenue will decline over the long-term as it continues to scale and grow its business. &#160;The Company&#8217;s long-term objective is for unallocated corporate G&amp;A to reach between 6% and 8% of revenue. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;">Net income in Q4 FY 2021 totaled $9.4 million, or $0.06 per diluted share, compared to a net loss of $(1.8) million, or $(0.16) per diluted share in Q4 FY 2020. Net income in Q4 FY 2021 was driven by gains of $4.9 million of PPP loan forgiveness and $8.4 million of fair value remeasurement on the convertible notes issued in September 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;">Adjusted EBITDA increased to $4.3 million in Q4 FY 2021, compared to $156,000 in Q4 FY 2020 due to improved margins on higher revenue. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 4pt 0pt;"><b style="font-weight:bold;">12M FY 2021 Review </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;">Total revenue increased 48.2% to $89.6 million in 12M FY 2021, from $60.5 million in the prior year period, driven primarily by our Service segment. Service segment revenue for 12M FY 2021 increased 50.1% to $85.8 million, from $57.2 million in the prior year period. The majority of the increase in revenue was due to internal growth, augmented by $11.8 million of incremental revenue from the acquisitions of HistoTox Labs, Bolder BioPATH, and Gateway Pharmacology.<b style="font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt;">Cost of Service revenue as a percentage of Service revenue decreased to 66.7% in 12M FY 2021, from 70.0 % in the prior year period. The reduction in Cost of Service revenue as a percentage of Service revenue is due primarily to improved operating leverage and the greater utilization of recently expanded capacity. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt;">Product segment revenue increased 14.6% to $3.8 million in 12M FY 2021, from $3.3 million in the prior year period, reflecting higher sales of analytical instruments, partially offset by a decrease in Culex in-vivo sampling systems and other instruments.<b style="font-weight:bold;"> &#160;</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;">Cost of Product revenue as a percentage of Product revenue in 12M FY 2021 decreased to 58.0%, from 67.6% in the prior year period, due to expense reductions implemented in the last half of FY 2020 and improved margins on higher sales. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;">Operating expenses in 12M FY 2021 increased year over year by 68.0%, or $14.5 million, as the Company continued to build the infrastructure for anticipated growth, which included additional headcount, recruiting, relocation expense, sales commissions, non-cash stock compensation expense, costs associated with acquisitions and investments in business development to build out new service offerings. For the 12M FY 2021, the Company began investing in additional service offerings such as software solutions and human resources to support existing internal expertise in the area of SEND (Standard for the Exchange of Nonclinical Data) data management and delivery investments in SEND reporting, safety pharmacology, clinical pathology, medical device pathology, biotherapeutics and genetic toxicology. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;">Net income for 12M FY 2021 totaled $10.9 million, or $0.19 per diluted share, compared to a net loss of $(4.7) million, or $(0.43) per diluted share, in the prior year period. Net income in FY 2021 was driven by gains of $4.9 million of PPP loan forgiveness in the fourth quarter, $8.4 million of fair value remeasurement on the convertible notes issued in September 2021 and the YTD impact of a non-cash tax benefit of $5.0 million relating to a partial release of the Company&#8217;s valuation allowance for deferred tax liabilities acquired with the acquisitions of Bolder BioPATH and Gateway. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;">Adjusted EBITDA increased 223.5% to $9.3 million for 12M FY 2021, compared to $2.9 million for 12M FY 2020 due to improved margins on higher revenue. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt -0.7pt 4pt 0pt;"><font style="font-size:11pt;font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:28.8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.7pt 4pt 0pt;"><b style="font-weight:bold;">Cash Provided by Operating Activities and Financial Condition </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;">As of September 30, 2021, the Company had $156.9 million in cash and cash equivalents, $163.9 million of current and long-term debt, a $0 balance and $5.0 million of availability on its general line of credit, and a $1.7 million balance on a $3.0 million equipment loan. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;">In September 2021, the Company closed an offering of $140.0 million aggregate principal amount of 3.25% convertible senior notes due 2027. The gross proceeds to the Company were approximately $134.2 million after deducting the initial purchaser&#8217;s discounts and commissions and estimated offering expenses. A portion of the proceeds, together with a new senior secured term loan facility agreement entered into in November 2021 were used in November 2021 to close on the acquisition of Envigo and to repay the outstanding bank debt under the Company&#8217;s credit facilities that were in place as of September 30, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;">Cash provided by operating activities was $10.7 million for 12M FY 2021, compared to $1.3 million in 12M FY 2020. For the twelve months ended September 30, 2021, cash from operations, cash on hand, $2.1 million from an equipment line of credit and $2.8 million on borrowings from a term loan together funded capital expenditures of $12.5 million for the investment in laboratory equipment to increase capacity at all locations, facility improvements at the Fort Collins location and the purchase and expansion of our St. Louis facility. Borrowings on term loans totaling $15.0 million and proceeds from the issuance of common stock together funded the cash paid for acquisitions. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt -0.7pt 4pt 0pt;"><font style="display:inline-block;width:327.75pt;"></font><font style="font-size:11pt;font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.7pt 4pt 0pt;"><b style="font-weight:bold;">Conference Call</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;">Management will host a conference call on Thursday, December 16, 2021, at 4:30 pm ET to discuss fourth quarter and fiscal year 2021 reported results. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;"> <font style="margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;">Interested parties may participate in the call by dialing:</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt -0.9pt 0pt 18pt;"><font style="display:inline-block;font-family:'Times New Roman';font-size:11pt;min-width:9pt;text-indent:0pt;white-space:nowrap;">&#9679;</font><font style="font-size:11pt;">(877) 407-9753 (Domestic)</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt -0.9pt 0pt 18pt;"><font style="display:inline-block;font-family:'Times New Roman';font-size:11pt;min-width:9pt;text-indent:0pt;white-space:nowrap;">&#9679;</font><font style="font-size:11pt;">(201) 493-6739 (International)</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.17;text-align:justify;margin:0pt 3.6pt 0pt 0pt;">The live conference call webcast will be accessible in the Investors section of the Company&#8217;s website and directly via the following link:</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.17;text-align:justify;margin:0pt 3.6pt 0pt 0pt;"><font style="font-size:11pt;">https://78449.themediaframe.com/dataconf/productusers/bas2/mediaframe/47348/indexl.html</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.17;text-align:justify;margin:0pt 3.6pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;">For those who cannot listen to the live broadcast, an online replay will be available in the Investors section of Inotiv&#8217;s web site at: https://www.inotivco.com/investors/investor-information/.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;"><font style="font-size:11pt;font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.7pt 4pt 0pt;"><b style="font-weight:bold;">Non-GAAP to GAAP Reconciliation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 3.6pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;">This press release contains financial measures that are not calculated in accordance with generally accepted accounting principles in the United States (GAAP), including Adjusted EBITDA for the three and twelve months ended September 30, 2021 and 2020 and selected business segment information for those periods. Adjusted EBITDA as reported herein refers to a financial performance measure that excludes from net income (loss) income statement line items interest expense and income taxes (benefit) expense, as well as non-cash charges for depreciation and amortization, stock option (benefit) expense, <font style="letter-spacing:-0.2pt;">United Kingdom lease liability reversal benefit, non-recurring acquisition and integration costs and other non-recurring third-party costs, such as </font>recruiting costs, consulting fees related to the adoption of two accounting standards, and expenses for rebranding and new website launch. &#160;The adjusted business segment information excludes from operating income and unallocated corporate G&amp;A these same expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:28.8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;">The Company believes that these non-GAAP measures provide useful information to investors. Among other things, they may help investors evaluate the Company&#8217;s ongoing operations. They can assist in making meaningful period-over-period comparisons and in identifying operating trends that would otherwise be masked or distorted by the items subject to the adjustments. Management uses these non-GAAP measures internally to evaluate the performance of the business, including to allocate resources. Investors should consider these non-GAAP measures as supplemental and in addition to, not as a substitute for or superior to, measures of financial performance prepared in accordance with GAAP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;"><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt -0.9pt 0pt 0pt;">Management has chosen to provide this supplemental information to investors, analysts, and other interested parties to enable them to perform additional analyses of our results and to illustrate our results giving effect to the non-GAAP adjustments shown in the reconciliation. Management strongly encourages investors to review the Company&#39;s consolidated financial statements and publicly filed reports in their entirety and cautions investors that the non-GAAP measures used by the Company may differ from similar measures used by other companies, even when similar terms are used to identify such measures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;margin:0pt 0pt 4pt 0pt;"><b style="font-weight:bold;">About the Company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt;">Inotiv, Inc.<b style="font-weight:bold;"> </b>is a leading contract research organization dedicated to<font style="background-color:#ffffff;"> providing nonclinical and analytical drug discovery and development services</font> and research models and related products and services. The Company&#8217;s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&amp;D projects, all while working together to build a healthier and safer world. &#160;Further information about Inotiv can be found here: https://www.inotivco.com/.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our services and products, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, </i>the timing of acquisitions and the successful closing, integration and business and financial impact thereof,<i style="font-style:italic;"> the impact of the COVID-19 pandemic on the economy, demand for our services and products and our operations, including the measures taken by governmental authorities to address the pandemic, which may precipitate or exacerbate other risks and/or uncertainties and various other market and operating risks, including those detailed in the Company&#39;s filings with the U.S. Securities and Exchange Commission.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:115.1%;"><tr style="height:12.75pt;"><td style="vertical-align:top;width:48.44%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 4pt -5.75pt;"><b style="font-weight:bold;">Company Contact</b></p></td><td style="vertical-align:top;width:16.7%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:34.84%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><b style="font-weight:bold;">Investor Relations</b></p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:top;width:48.44%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;">Inotiv, Inc. </p></td><td style="vertical-align:top;width:16.7%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:34.84%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;">The Equity Group Inc.</p></td></tr><tr style="height:13.45pt;"><td style="vertical-align:top;width:48.44%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;">Beth A. Taylor, Chief Financial Officer</p></td><td style="vertical-align:top;width:16.7%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:34.84%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;">Kalle Ahl, CFA</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:top;width:48.44%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;">(765) 497-8381</p></td><td style="vertical-align:top;width:16.7%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:34.84%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;">(212) 836-9614</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:top;width:48.44%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;">btaylor@inotivco.com</font></p></td><td style="vertical-align:top;width:16.7%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:34.84%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><u style="color:#ff8f1c;text-decoration:underline;text-decoration-color:#ff8f1c;">kahl@equityny.com</u></p></td></tr><tr style="height:13.45pt;"><td style="vertical-align:top;width:48.44%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:16.7%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:34.84%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:top;width:48.44%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:16.7%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:34.84%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;">Devin Sullivan</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:top;width:48.44%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:16.7%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:34.84%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;">(212) 836-9608</p></td></tr><tr style="height:48.6pt;"><td style="vertical-align:top;width:48.44%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:16.7%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:34.84%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 0pt -5.4pt;"><u style="color:#ff8f1c;text-decoration:underline;text-decoration-color:#ff8f1c;">dsullivan@equityny.com</u></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt;">Financial Tables Follow:</p></div><div style="clear:both;margin-bottom:28.8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">INOTIV, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(In thousands, except per share amounts) </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt 14.4pt 0pt -7.2pt;"><font style="font-size:10pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt 14.4pt 0pt -7.2pt;"><font style="font-size:10pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:99.31%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td colspan="2" style="vertical-align:middle;width:30.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Three Months Ended </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td colspan="2" style="vertical-align:middle;width:30.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Twelve Months Ended </p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td colspan="2" style="vertical-align:middle;width:30.98%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">September 30,</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td colspan="2" style="vertical-align:middle;width:30.98%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">September 30,</p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:middle;width:15.49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:middle;width:15.49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2020</p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(unaudited)</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">(unaudited)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Service revenue</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$28,974 </p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$14,992 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$85,832 </p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$57,177 </p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Product revenue</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                       1,102 </font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                       782 </font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 3,773 </font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                      3,292 </font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">             Total revenue</font></p></td><td style="vertical-align:middle;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                  30,076 </font></p></td><td style="vertical-align:middle;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                  15,774 </font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">               89,605 </font></p></td><td style="vertical-align:middle;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                    60,469 </font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Cost of service revenue</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                  19,058 </font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                  10,655 </font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">               57,262 </font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                    40,006 </font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Cost of product revenue</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                       710 </font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                       496 </font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                    2,187 </font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                      2,226 </font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">             Total cost of revenue</font></p></td><td style="vertical-align:middle;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                  19,768</font></p></td><td style="vertical-align:middle;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                  11,151 </font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">               59,449 </font></p></td><td style="vertical-align:middle;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                    42,232 </font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Gross profit</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                    10,308 </font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                    4,623 </font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">               30,156</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                      18,237</font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Operating expenses:</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">      Selling</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">1,174 </p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">701 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">3,517</p></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">3,373                      </font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">      Research and development</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                       115 </font></p></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                       76 </font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">405 </p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                         617 </font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">      General and administrative</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                    11,791 </font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                    4,772 </font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">               30,375 </font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                      16,977 </font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">      <font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">      Start up costs</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">636</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">445</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">1,477</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">333</p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">              Total operating expenses</font></p></td><td style="vertical-align:middle;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                    13,716 </font></p></td><td style="vertical-align:middle;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                    5,994 </font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">               35,774 </font></p></td><td style="vertical-align:middle;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                      21,300 </font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Operating loss</p></td><td style="vertical-align:middle;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                     (3,408)</font></p></td><td style="vertical-align:middle;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                     (1,371)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                   (5,618)</font></p></td><td style="vertical-align:middle;width:15.49%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                     (3,063)</font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">   Interest expense</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                     (520)</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                     (405)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                   (1,683)</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                        (1,490)</font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">   Other income </font></p></td><td style="vertical-align:bottom;width:15.49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                       13,240 </font></p></td><td style="vertical-align:bottom;width:15.49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                        21 </font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">13,420 </p></td><td style="vertical-align:middle;width:15.49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                           15 </font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Net income (loss) before income taxes</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                     9,312</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                     (1,774)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                6,119</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                     (4,538)</font></p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Income tax (benefit) expense </p></td><td style="vertical-align:middle;width:15.49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                       (70) </font></p></td><td style="vertical-align:middle;width:15.49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                         18 </font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                      (4,776) </font></p></td><td style="vertical-align:bottom;width:15.49%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                         147 </font></p></td></tr><tr style="height:1pt;"><td rowspan="2" style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Net income (loss)</p></td><td rowspan="2" style="vertical-align:middle;width:15.49%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$9,382</p></td><td rowspan="2" style="vertical-align:middle;width:15.49%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">($1,792)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td rowspan="2" style="vertical-align:middle;width:15.49%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$10,895</p></td><td rowspan="2" style="vertical-align:middle;width:15.49%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">($4,685)</p></td></tr><tr style="height:1pt;"><td style="display:none;vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="display:none;vertical-align:middle;width:15.49%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="display:none;vertical-align:middle;width:15.49%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="display:none;vertical-align:middle;width:15.49%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="display:none;vertical-align:middle;width:15.49%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Basic net income (loss) per share</p></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$0.59</p></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">($0.16)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$0.83</p></td><td style="vertical-align:bottom;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">($0.43)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Diluted net income (loss) per share</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$0.06</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">($0.16)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$0.19</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">($0.43)</p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Weighted common shares outstanding:</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">       Basic</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">15,912</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">10,976</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">13,191</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">10,851</p></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:35.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">       Diluted</font></p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">16,473</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">10,976</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">13,865</p></td><td style="vertical-align:middle;width:15.49%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">10,851</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:9pt;font-style:italic;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:9pt;font-style:italic;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Note &#8211; </i><i style="font-size:10pt;font-style:italic;">Certain prior quarter and year to date amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:28.8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">INOTIV, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CONDENSED CONSOLIDATED BALANCE SHEETS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> (In thousands, except share amounts)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100.64%;"><tr style="height:14.5pt;"><td rowspan="2" style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">September 30,</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">September 30,</p></td></tr><tr style="height:15pt;"><td style="display:none;vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:18.47%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:middle;width:4.45%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:15.07%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2020</p></td></tr><tr style="height:12pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:14.5pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Assets</b></p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Current assets:</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$138,924 </p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$1,406 </p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Restricted cash</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">18,000</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#8212;</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Accounts receivable</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:18pt;margin:0pt;"><font style="white-space:pre-wrap;">Trade, net of allowance of $668 at September 31, 2021 and $561 at               September 30, 2020</font></p></td><td style="vertical-align:bottom;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">20,734</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">8,681</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:18pt;margin:0pt;">Unbilled revenues and other</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">7,630</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">2,142</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Inventories, net</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">602</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">700</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Prepaid expenses and other current assets</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">3,129</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">2,371</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Total current assets</p></td><td style="vertical-align:middle;width:18.47%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">189,019</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">15,300</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Property and equipment, net</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">47,978</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">28,729</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Operating lease right-of use-assets, net</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">8,358</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">4,001</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Finance lease right-to use assets, net</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">60</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">4,778</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Goodwill</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">51,927</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">4,368</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Other intangible assets, net</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">24,233</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">4,261</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Other assets</p></td><td style="vertical-align:middle;width:18.47%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">281</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">156</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">                 Total assets</font></p></td><td style="vertical-align:middle;width:18.47%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$321,856 </p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$61,593 </p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Liabilities and shareholders&#8217; equity</b></p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Current liabilities:</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Accounts payable</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$6,163 </p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$3,196 </p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Accrued expenses</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">8,777</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">2,856</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Current portion of contingent liability</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">167</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#8212;</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Customer advances</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">26,614</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">11,392</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Capex line of credit</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">1,749</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">2,613</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Current portion on long-term operating lease</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">1,959</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">866</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Current portion of long-term finance lease</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">24</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">4,728</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Current portion of long-term debt </p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">9,656</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">5,991</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Total current liabilities</p></td><td style="vertical-align:middle;width:18.47%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">55,109</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">31,642</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Long-term operating leases, net</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">6,554</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">3,344</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Long-term finance leases, net</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">39</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">44</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Long-term portion of contingent liability</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">473</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#8212;</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Long-term debt, less current portion, net of debt issuance costs</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">154,209</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">18,826</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Deferred tax liabilities</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">344</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">141</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">                 Total liabilities</font></p></td><td style="vertical-align:middle;width:18.47%;border-bottom:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">216,728</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;border-bottom:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">53,997</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Shareholders&#8217; equity:</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Preferred shares, authorized 1,000,000 shares, no par value:</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:36pt;margin:0pt;">No Series A shares at September 30, 2021 and 25 Series A shares at September 30, 2020 issued and outstanding at $1,000 stated value </p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#8212;</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">25</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Common shares, no par value: </p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">           Authorized 19,000,000 shares; 15,931,485 issued and outstanding at             September 30, 2021 and 10,977,675 at September 30, 2020</font></p></td><td style="vertical-align:bottom;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                        3,945 </font></p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 2,706 </font></p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Additional paid-in capital</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                      112,198 </font></p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">               26,775 </font></p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Accumulated deficit</p></td><td style="vertical-align:middle;width:18.47%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                     (11,015)</font></p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">              (21,910)</font></p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;"> Total shareholders&#8217; equity     </font></p></td><td style="vertical-align:middle;width:18.47%;border-bottom:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">105,128</p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;border-bottom:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">7,596</p></td></tr><tr style="height:7.2pt;"><td style="vertical-align:middle;width:61.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">                 Total liabilities and shareholders&#8217; equity</font></p></td><td style="vertical-align:middle;width:18.47%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$321,856 </p></td><td style="vertical-align:middle;width:4.45%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:15.07%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">$61,593 </p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-size:10pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:28.8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">INOTIV, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">RECONCILIATION OF GAAP TO NON-GAAP EARNINGS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> (In thousands)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Unaudited)</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:auto;width:105.29%;"><tr style="height:15.65pt;"><td rowspan="3" style="vertical-align:middle;width:43.82%;border-bottom:1.0pt solid #ffffff;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td colspan="3" style="vertical-align:middle;width:26.23%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Three&#160;Months&#160;Ended</p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td colspan="3" style="vertical-align:middle;width:26.29%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Twelve&#160;Months&#160;Ended</p></td></tr><tr style="height:16pt;"><td style="display:none;vertical-align:middle;width:43.82%;border-bottom:1.0pt solid #ffffff;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td colspan="3" style="vertical-align:middle;width:26.23%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">September 30,</p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td colspan="3" style="vertical-align:middle;width:26.29%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">September 30,</p></td></tr><tr style="height:15pt;"><td style="display:none;vertical-align:middle;width:43.82%;border-bottom:1.0pt solid #ffffff;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.63%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:middle;width:11.67%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2020</p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.63%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:middle;width:11.73%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2020</p></td></tr><tr style="height:14.5pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">GAAP&#160;Net&#160;income (loss)</p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $     9,382</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.67%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $      (1,792)</font></p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $    10,895</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $    (4,685)</font></p></td></tr><tr style="height:14.5pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Add back (a):</p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.67%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:14.5pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:18pt;margin:0pt;">Interest&#160;expense</p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $        520 </font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.67%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $           405</font></p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $       1,683 </font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $       1,490 </font></p></td></tr><tr style="height:14.5pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:18pt;margin:0pt;">Income&#160;taxes (benefit) expense</p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">     $       (70)</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.67%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $             18 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $      (4,776)</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $          147 </font></p></td></tr><tr style="height:14.5pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:18pt;margin:0pt;">Depreciation and amortization</p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $     2,084 </font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.67%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $        1,212</font></p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $       6,268 </font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $       4,074</font></p></td></tr><tr style="height:14.5pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:18pt;margin:0pt;">Stock&#160;option&#160;expense</p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $        747 </font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.67%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $           160 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $       1,786 </font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $          540 </font></p></td></tr><tr style="height:14.5pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:18pt;margin:0pt;">United Kingdom lease liability reversal benefit (1)</p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $             -</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.67%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $             11</font></p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $       (179)</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $       (180)</font></p></td></tr><tr style="height:14.5pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:18pt;margin:0pt;">Acquisition and integration costs (2)(3)</p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $     4,249</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.67%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $                - </font></p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $       5,377 </font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $          339 </font></p></td></tr><tr style="height:14.5pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:18pt;margin:0pt;">Startup costs</p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$        636</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:11.67%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$           101</font></p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$       1,477</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:11.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$          333</font></p></td></tr><tr style="height:18.9pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:18pt;margin:0pt;">Other non-recurring, third-party costs</p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> - </font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:11.67%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $             41</font></p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> - </font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:11.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $          823 </font></p></td></tr><tr style="height:14.5pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:18pt;margin:0pt;">PPP loan forgiveness</p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$  (4,851)</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:11.67%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$               -</font></p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:11.63%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$    (4,851)</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:11.73%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$               -</font></p></td></tr><tr style="height:15pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><font style="white-space:pre-wrap;">        Gain on fair value remeasurement of convertible            notes  (4)</font></p></td><td style="vertical-align:middle;width:11.63%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$  (8,362)</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:11.67%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$               -</font></p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:11.63%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$    (8,362)</font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:11.73%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$               -</font></p></td></tr><tr style="height:15pt;"><td style="vertical-align:middle;width:43.82%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Adjusted EBITDA (b)</p></td><td style="vertical-align:middle;width:11.63%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $     4,335 </font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.67%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $          156</font></p></td><td style="vertical-align:bottom;white-space:normal;width:3.64%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.63%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $      9,318 </font></p></td><td style="vertical-align:middle;width:2.92%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.73%;border-bottom:2.25pt double #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $       2,881 </font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-style:italic;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:justify;">Adjustments to certain GAAP reported measures for the three and twelve months ended September 30, 2021 and 2020 include, but are not limited to, the following:</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:justify;">We benefited from the initial reduction in our United Kingdom lease liability for a portion of the reserve for lease related liabilities that were no longer owed due to the statute of limitations.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:justify;">For the three and twelve months ended September 30, 2021, charges for legal services, accounting services, travel, and other related activities in connection with the acquisitions of HistoTox Labs, Bolder BioPATH, Gateway Pharmacology, Envigo and Plato BioPharma, Inc</font><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-align:justify;">.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:justify;">For the twelve months ended September 30, 2020, charges for legal services, accounting services, travel, and other related activities in connection with the acquisition of Preclinical Research Services. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:justify;">For the three and twelve months ended September 30, 2021, gain of $8,362 resulting from the fair value remeasurement of the conversion feature of the convertible senior note.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;text-align:justify;">Adjusted EBITDA&#160;- Earnings before interest expense, income taxes (benefit) expense, depreciation and amortization, stock option expense, United Kingdom lease liability reversal benefit and foreign currency impact on liability, non-recurring acquisition and integration costs, startup costs, other non-recurring third-party costs, PPP loan forgiveness and gain on fair value remeasurement of convertible notes.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:9pt;letter-spacing:-0.2pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:28.8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><font style="font-size:9pt;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">RECONCILIATION OF GAAP TO NON-GAAP SELECTED BUSINESS SEGMENT INFORMATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> (In thousands)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Unaudited)</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:auto;width:102.75%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:middle;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:middle;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:middle;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:middle;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:middle;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:middle;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td colspan="3" style="vertical-align:middle;width:32.1%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Three&#160;Months&#160;Ended</p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td colspan="3" style="vertical-align:middle;width:27.7%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Twelve&#160;Months&#160;Ended</p></td></tr><tr style="height:14.95pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td colspan="3" style="vertical-align:middle;width:32.1%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">September 30, 2021</p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td colspan="3" style="vertical-align:middle;width:27.7%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">September 30, 2021</p></td></tr><tr style="height:14.95pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:13.39%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:middle;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:middle;width:12.57%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2020</p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:middle;width:11.42%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:middle;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:middle;width:11.8%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">2020</p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Services</b></p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">        $ 28,974 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">    $14,992 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">   $85,832 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">    $57,177 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Operating income</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">           4,962 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       2,459</font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       13,986 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       8,852 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Operating income as a % of total revenue</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">16.5%</p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="background-color:#ffff00;font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">15.6%</p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="background-color:#ffff00;font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">15.6%</p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="background-color:#ffff00;font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">14.6%</p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Add back (c):</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">           1,855 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          1,095 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       5,320 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       3,271 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Stock option expense</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -  </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">            -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          (17)</font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">United Kingdom lease liability reversal benefit (5)</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Acquisition and integration costs (6)(7)</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Startup costs</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">              636 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          101 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          1,477 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          333</font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Other non-recurring, third party costs</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">            41 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">823 </p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Total non-GAAP adjustments to operating income</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          $ 2,491 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       $1,237 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">     $  6,797 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">     $  4,410 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Non-GAAP operating income (d)</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">         $  7,453 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       $3,696 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">  $  20,783 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">      $ 13,262 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Non-GAAP operating income as a % of total revenue</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">24.8%</p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">23.4%</p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">23.2%</p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">21.9%</p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Products</b></p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">            $ 1,102 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          $782</font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">     $  3,773</font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">     $  3,292 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Operating income/(loss)</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">           10</font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          202 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">        (437)</font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Operating income/(loss) as a % of total revenue</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">0.0%</p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">0.1%</p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">0.2%</p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-0.7%</p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Add back (c):</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                  8 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">              5</font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">            34 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">            24 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Stock option expense</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">United Kingdom lease liability reversal benefit</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Acquisition and integration costs (6)(7)</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Startup costs</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Other non-recurring, third party costs</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Total non-GAAP adjustments to operating income/(loss)</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          $        8 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">              $5 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">         $   34 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       $     24 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Non-GAAP operating income/(loss) (d)</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">           $     8 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">            $15 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">    $      236 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">   $     (413)</font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Non-GAAP operating income/(loss) as a % of total revenue</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">0.0%</p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">0.1%</p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">0.3%</p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-0.7%</p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Unallocated Corporate G&amp;A</b></p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">      $   (8,370)</font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">     $(3,840)</font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$   (19,806)</font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$    (11,478)</font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Unallocated corporate G&amp;A as a % of total revenue</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">         -27.8%</font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-24.3%</p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-22.1%</p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-19.0%</p></td></tr></table></div></div><div style="clear:both;margin-bottom:28.8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:auto;width:102.75%;"><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Add back (c):</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">              221 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          227 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          914 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          779 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Stock option expense</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">              747 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          160 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       1,786 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          557 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">United Kingdom lease liability reversal benefit</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          28</font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">        (179)</font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">        (180)</font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Acquisition and integration costs (6)(7)</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">              4,249 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       5,377 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          339 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Startup costs</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Other non-recurring, third party costs</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Total non-GAAP adjustments to unallocated corporate G&amp;A</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">         $  5,217 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          $415 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">     $  7,898 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">   $    1,495 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Non-GAAP unallocated corporate G&amp;A</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">      $   (3,153)</font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">     $(3,425)</font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">  $ (11,908)</font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">  $  (9,983)</font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Non-GAAP unallocated corporate G&amp;A as a % of total revenue</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-10.5%</p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-21.7%</p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-13.3%</p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-16.5%</p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">      $   30,076 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">    $15,774 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">  $  89,605 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> $   60,469 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Operating (loss)</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">         (3,408)</font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">        (1,371)</font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">     (5,618)</font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">     (3,063)</font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Operating (loss) as a % of total revenue</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-11.3%</p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-8.7%</p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-6.3%</p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">-5.1%</p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Add back (c):</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">           2,084 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       1,327 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       6,268 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       4,074 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Stock option expense</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">              747</font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          160 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       1,786</font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          540 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">United Kingdom lease liability reversal benefit (4)</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          28</font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          (179)</font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">        (180)</font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Acquisition and integration costs (6)(7)</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">              4,249 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       5,377 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          339 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Startup costs</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">              636</font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          101 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          1,477 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          333</font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:9pt;margin:0pt;">Other non-recurring, third party costs</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">                 -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">            41 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">             -   </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          823 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Total non-GAAP adjustments to operating income</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">        $   7,716 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">       $1,657 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">      $14,729 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$       5,929 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Non-GAAP operating income (d)</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">    $      4,308 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">          $286 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">    $   9,111 </font></p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;">$       2,866 </font></p></td></tr><tr style="height:14.45pt;"><td style="vertical-align:bottom;white-space:normal;width:34.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Non-GAAP operating income as a % of total revenue</p></td><td style="vertical-align:bottom;white-space:normal;width:13.39%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">14.3%</p></td><td style="vertical-align:bottom;white-space:normal;width:6.14%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:12.57%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">1.8%</p></td><td style="vertical-align:bottom;white-space:normal;width:5.85%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.42%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">10.2%</p></td><td style="vertical-align:bottom;white-space:normal;width:4.48%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:bottom;white-space:normal;width:11.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;">4.7%</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(c)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:justify;">Adjustments to certain GAAP reported measures for the three and twelve months ended September 30, 2021 and 2020 include, but are not limited to, the following:</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(5)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:justify;">We benefited from the initial reduction in our United Kingdom lease liability for a portion of the reserve for lease related liabilities that were no longer owed due to the statute of limitations.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(6)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:justify;">For the three and </font><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:justify;">twelve months ended September 30</font><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:justify;">, 2021, charges for legal services, accounting services, travel, and other related activities in connection with the acquisitions of HistoTox Labs and Bolder BioPATH. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(7)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:justify;">For the twelve months ended September 30, 2020, charges for legal services, accounting services, travel, and other related activities in connection with the acquisition of Preclinical Research Services. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(d)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;text-align:justify;">Adjusted operating income&#160;&#8211; Operating income before depreciation and amortization, stock option expense, United Kingdom lease liability reversal benefit and foreign currency impact on liability, non-recurring acquisition and integration costs, startup costs and other non-recurring third-party costs.</font></td></tr></table></div><div style="clear:both;margin-bottom:28.8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>notv-20211215.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8003.26990 -->
<!--Based on XBRL 2.1-->
<!--Created on: 12/16/2021 9:03:34 PM-->
<!--Modified on: 12/16/2021 9:03:34 PM-->
<xsd:schema targetNamespace="http://www.inotivco.com/20211215" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:notv="http://www.inotivco.com/20211215">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.inotivco.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="notv-20211215_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="notv-20211215_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>notv-20211215_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8003.26990 -->
<!--Based on XBRL 2.1-->
<!--Created on: 12/16/2021 9:03:34 PM-->
<!--Modified on: 12/16/2021 9:03:34 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>notv-20211215_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8003.26990 -->
<!--Based on XBRL 2.1-->
<!--Created on: 12/16/2021 9:03:34 PM-->
<!--Modified on: 12/16/2021 9:03:34 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="notv-20211215.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.inotivco.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.inotivco.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType_637752854144786503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_637752854144786503" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_637752854144786503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_637752854144786503" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_637752854144786503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_637752854144786503" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_637752854144786503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_637752854144786503" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_637752854144786503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_637752854144786503" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_637752854144786503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_637752854144786503" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_637752854144786503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_637752854144786503" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_637752854144786503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_637752854144786503" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_637752854144786503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_637752854144786503" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_637752854144786503" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_637752854144786503" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_637752854144796502" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_637752854144796502" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_637752854144796502" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_637752854144796502" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_637752854144796502" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_637752854144796502" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_637752854144796502" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_637752854144796502" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_637752854144796502" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_637752854144796502" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_637752854144796502" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_637752854144796502" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_637752854144796502" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_637752854144796502" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_637752854144796502" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_637752854144796502" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_637752854144796502" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_637752854144796502" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_637752854144796502" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_637752854144796502" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_637752854144796502" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_637752854144796502" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_637752854144796502" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_637752854144796502" order="22" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>notv-20211215x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="notv-20211215.xsd" xlink:type="simple"/>
    <context id="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000720154</identifier>
        </entity>
        <period>
            <startDate>2021-12-15</startDate>
            <endDate>2021-12-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Tc_g6PSrfgzkUCGMC3FqSw6ug_2_1">0000720154</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Tc_bF_mp4QupEOR7nGMPYlqaQ_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Narr_77YHLgdt9EOJdoRGxfdltA">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Narr_kjrm5dZRx0uwB_oDNVWijg">2021-12-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Tc_GBSMdiHo9EKrNvABLWTzbA_1_0">INOTIV, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Tc_kn-HP-DlOE-BhkMOMgr5hA_1_0">IN</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Tc_FbaY2sEQ_UOs3N9b9MJ28Q_1_2">0-23357</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Tc_1L0saysr7U2Mw1LKje1K5w_1_4">35-1345024</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Tc_0F0MZW2n8UuqnEdj-COOlQ_1_0">2701 Kent Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Narr_dxNck9YGX0yOEU3jCr6_0g">West Lafayette</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Narr_56AWTPCfZU6x2HD-m4xhOw">IN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Tc_VfQEKD-CuEOaXVzelz1DJg_2_2">47906-1382</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Narr_uboUPmLclUKdTzw1ME0bkw">765</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Narr_KIatB_QdzkqtB39YVU3ngQ">463-4527</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Narr_cBx0Vi5kfUaBBQxkcy5T1g">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Narr_vUdGAJZB5EOrITjTrJBu3Q">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Narr_bazxvagHMkqhQdU4Xi0NnQ">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Narr_hXlUe9-FSUyol3vQ75V3JQ">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Tc_K25YpyGdHkKeYh4P7TQvaQ_1_0">Common Shares</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Tc_lIajkjObiUiPopfb4pUrJg_1_2">NOTV</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Narr_0dww8cleOUeo_nPe3BfKMw">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw"
      id="Narr_xy7fkM06fkSyvTkggzYJ6g">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139951422655640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 15, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 15,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-23357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INOTIV, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">IN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">35-1345024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2701 Kent Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">West Lafayette<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">47906-1382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">463-4527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NOTV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000720154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M>FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ
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M4')O<',O8V]R92YX;6Q02P$"% ,4    "  $@I!3F5R<(Q &  "<)P  $P
M            @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M  2"D%.:F=.1)@0  $<0   8              " @0P(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    "  $@I!3GZ ;\+$"  #B#   #0
M            @ %H#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    (  2"D%.7
MBKL<P    !,"   +              "  40/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    (  2"D%,<.&7J/P$  #P"   /              "  2T0  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    "  $@I!3)!Z;HJT   #X 0  &@
M        @ &9$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    "  $@I!399!YDAD!  #/ P  $P              @ %^$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #($P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="notv-20211215x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inotivco.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="notv-20211215x8k.htm">notv-20211215x8k.htm</File>
    <File>notv-20211215.xsd</File>
    <File>notv-20211215_lab.xml</File>
    <File>notv-20211215_pre.xml</File>
    <File>notv-20211215xex99d1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "notv-20211215x8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "notv-20211215x8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "notv-20211215_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "notv-20211215_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "notv-20211215.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "notv",
   "nsuri": "http://www.inotivco.com/20211215",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "notv-20211215x8k.htm",
      "contextRef": "Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document and Entity Information",
     "role": "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "notv-20211215x8k.htm",
      "contextRef": "Duration_12_15_2021_To_12_15_2021_WRptgUGIPkG1mQ0wvcdcWw",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.inotivco.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001558370-21-016882-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-21-016882-xbrl.zip
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MY8#G>VV5R8?/V531OP,2OA"!Q7Y$%I3%J8X64/%_?1^=<<$R&-X$M!'0V%$
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M$5\BN"QPX*R]'LK?IJP5+RNMGYS\]S7J@RSGH T^?*+R\4]02P,$%     @
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MCV?ZG!H0G$<A^XS1.M(UW^"5[.K$_<+DWQ#[E*&/LGD).;R.\KQ&FNB4=>T
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MH,Z%%W PS_<<@KL5S>&1NQYP*=GX<R%,H.,T/L5;O, T$ CB%H"+=8 S<5@
MN#?[<]%"4DV:APN2 (J&2XFV((YUO "#Z(3L( T'3##:H$/0?GB("3'&E077
MX,?&+O;&"RYJF41\3!G:26(2C'FL!%#W,,GH!1&8S9L,3Z)9M,==VIT.4/5
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M.HY3BI9B@?D(UY4D:4G2FY#TZ0C_!F0Z_WAQ\^FT8%*A+=5=-J7TGJ5HFK9
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M1?9#(]'0:0R(A@XC[K*VBOG@8,B-4Y%,SE@$I@Q5<RON;Q9.:'PP95YQ9#C
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MIN@;YXGD"BEVFJ\:OD0C/O8&C3JB.?P)X"&O,A6[_C>X.()5<PS,DDD>6/I
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M@H?]T@@V,ETDY;=!$5@P7[O2QRD)K*X$UDC16B2POE&17]]>J_K;MV_$#YV
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MM,$VX5]S_EHO^/<4T]"D=VHGL#<5PWZL3^^^R*?KBJX84BP5SA0@4C+M<@\
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M!0C)(4<9#GC "M^9Q?0D^Z.X#@LF+Q #W^C"-S0 4L1Q.K[S$*;)B9,F80Y
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M&N,.PW#T /]-DJG_V_\'4$L! A0#%     @ !(*04T&K::]: P  \ L  !$
M             ( !     &YO='8M,C R,3$R,34N>'-D4$L! A0#%     @
M!(*04Z@YF@YU!0  @#P  !4              ( !B0,  &YO='8M,C R,3$R
M,35?;&%B+GAM;%!+ 0(4 Q0    (  2"D%-!'R36=00  (4F   5
M      "  3$)  !N;W1V+3(P,C$Q,C$U7W!R92YX;6Q02P$"% ,4    "  $
M@I!3O'V?*%@9  #]L0  %               @ '9#0  ;F]T=BTR,#(Q,3(Q
M-7@X:RYH=&U02P$"% ,4    "  $@I!3!$6Q;'U)  "&1@0 &
M    @ %C)P  ;F]T=BTR,#(Q,3(Q-7AE>#DY9#$N:'1M4$L%!@     %  4
*30$  !9Q      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
